Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Merck KGaA initiates worldwide cancer study with BEC2

April 2, 1998

Genentech receives fast track product designation for Herceptin

April 2, 1998

Dendreon's dendritic cell-based immunotherapy reported at AACR

March 30, 1998

Novel fusion protein with potent activity in colon cancer models reported at AACR

March 30, 1998

U.S. patent issues for Immunex's soluble CD40 ligand

March 30, 1998

Canadian notice of patent allowance for Imutec's Virulizin

March 30, 1998

Promising preliminary results obtained with Melacine/Intron A combination in stage IV melanoma

March 27, 1998

Cytogen halts autologous lymphocyte therapy program

March 27, 1998

Coulter completes patient enrollment in Bexxar phase III trial

March 25, 1998

Phase II ImmTher trial begins in pediatric cancer patients

March 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...